CannAmerica Brands Corp.
CannAmerica Brands Corp.
Your view on CNNXF
Overview
What the company does, where it operates, and who runs it.
About CannAmerica Brands Corp.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Diana Anglin
- Headquarters
- 595 Howe Street, Vancouver, BC, CA
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Diana Anglin
- Headquarters
- 595 Howe Street, Vancouver, BC, CA
CannAmerica Brands Corp. owns a portfolio of brands of medical cannabis and recreational cannabis products.
The company primarily builds and maximizes the value of its brands by promoting, marketing, and licensing brands through various distribution channels, including dispensaries, wholesalers, and distributors in the states of Colorado, Nevada, Oklahoma, and Massachusetts.
It offers cannabis infused gummy products, disposable vape pens, distillate droppers, and shatter and wax concentrate products under the CannAmerica brand. The company is headquartered in Vancouver, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for CannAmerica Brands Corp., and the rating behind it. CNNXF last traded at $0.0000; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for CannAmerica Brands Corp.. Starting points for CannAmerica Brands Corp.: EPS -$0.06, beta -0.54 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for CannAmerica Brands Corp.. CannAmerica Brands Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for CannAmerica Brands Corp.. Trailing twelve-month EPS for CannAmerica Brands Corp. stands at -$0.06. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for CannAmerica Brands Corp.. CannAmerica Brands Corp. has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
CannAmerica Brands Corp. valued side by side against its closest peers. CannAmerica Brands Corp. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold CannAmerica Brands Corp., and how their positions are changing. At a $704 market value, institutional positions materially move CannAmerica Brands Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by CannAmerica Brands Corp. executives and directors. Shares of CannAmerica Brands Corp. have traded between $0.0000 and $0.0000 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming CannAmerica Brands Corp.. CannAmerica Brands Corp. is a $704 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming CannAmerica Brands Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for CannAmerica Brands Corp.. Coverage tracks CannAmerica Brands Corp. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.